KPV (Lys-Pro-Val) is a tripeptide corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone (alpha-MSH). Published research has characterized this minimal active fragment’s interactions with inflammatory signaling cascades, particularly its documented effects on NF-kB nuclear translocation and downstream cytokine expression in immune cell culture models.
The compound has been referenced in published immunology and mucosal biology literature examining peptide-mediated modulation of inflammatory responses. Researchers have documented KPV’s effects on MAP kinase signaling, interleukin production profiles, and epithelial barrier function parameters in standardized in-vitro assay systems.
Each 10mg vial contains lyophilized KPV with verified sequence identity and purity. The tripeptide format requires careful handling and storage to maintain stability, with analytical documentation confirming quality specifications.
For in-vitro research purposes only. Not intended for human or veterinary use.
